Literature DB >> 7236683

Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts.

M Hollemans, R O Elferink, P G De Groot, A Strijland, J M Tager.   

Abstract

The volume of the lysosomal compartment in cultured human skin fibroblasts was estimated from the distribution between the cells and the medium of tracer amounts of labelled methylamine and chloroquine, which accumulate in the lysosomes, 2,2-dimethyloxazolidine-2,4-dione, which accumulates in the soluble cytoplasmic compartment relative to the lysosomes, and sucrose, which is excluded by the cells. In a foetal fibroblast line, the fractional volume of the lysosomal compartment was 0.044 +/- 0.007 (n = 8). In fibroblasts from a patient with the I-cell disease, the fractional volume was 0.15. The fractional volume of the lysosomal compartment was used to calculate the intralysosomal pH from the accumulation of the weak bases in the cells. The mean value obtained was 5.29 +/- 0.04 (n = 8). In fibroblasts incubated with various concentrations of chloroquine, the fractional volume of the lysosomal compartment and the accumulation of chloroquine in the cells were used to calculate the concentration of chloroquine in the lysosomes. The intralysosomal concentration increased from 3 to 114 mM as the extracellular concentration increased from 1 to 100 microM. Concomitantly, the intralysosomal pH increased from 5.3 in the absence of chloroquine to 5.9 in the presence of 100 microM chloroquine. A similar increase in intralysosomal pH could be calculated in fibroblasts incubated with different concentrations of ammonia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236683     DOI: 10.1016/0005-2736(81)90226-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.

Authors:  Ryan S Funk; Jeffrey P Krise
Journal:  Mol Pharm       Date:  2012-04-06       Impact factor: 4.939

2.  The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant.

Authors:  M F Heath; W Jacobson
Journal:  Lung       Date:  1985       Impact factor: 2.584

3.  Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.

Authors:  S van Weely; M van den Berg; J A Barranger; M C Sa Miranda; J M Tager; J M Aerts
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

4.  Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence.

Authors:  S Ohkuma; Y Moriyama; T Takano
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Cultured human monocytes and fibroblasts solubilize calcium phosphate crystals.

Authors:  R W Evans; H S Cheung; D J McCarty
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

6.  N-Acetylneuraminic acid storage disease.

Authors:  J Baumkötter; M Cantz; K Mendla; W Baumann; H Friebolin; J Gehler; J Spranger
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 7.  Effects of exogenous amines on mammalian cells, with particular reference to membrane flow.

Authors:  R T Dean; W Jessup; C R Roberts
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

8.  Impaired clearance of free cystine from lysosome-enriched granular fractions of I-cell-disease fibroblasts.

Authors:  F Tietze; L H Rome; J D Butler; G S Harper; W A Gahl
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

9.  Pilocarpine-induced lysosomal enzyme secretion, from bovine trabecular meshwork cells.

Authors:  S Osterlin; K Fritz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-07       Impact factor: 3.117

10.  Studies on correlations between chloroquine-induced tissue damage and serum enzyme changes in the rat.

Authors:  E O Ngaha; M A Akanji; M A Madusolumuo
Journal:  Experientia       Date:  1989-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.